Book Value per Share: Fate Therapeutics Corp (FATE)

Public company logo of Fate Therapeutics Inc (FATE)

The confirmed price history on this chart demonstrates the performance of Fate Therapeutics, Inc. (FATE), which integrates ESG principles into immunotherapy and strictly monitors bio-waste disposal. The current indicator stands at 1.31, while the company systematically utilizes its existing cash reserves to fund costly clinical trials. The business relies on its own innovative platform for creating stem cell-derived cellular therapies in the US.

Fate Therapeutics Inc (FATE) - Accounting Value per Share from 07/04/2022 to 10/28/2026

Summary analytical data breakdowns for fatetherapeutics.com (FATE)

- price and consensus price forecast:
Stock Quotes Fate Therapeutics Corp|FATE - Analyst Forecast Prices
- market capitalization data:
Market Capitalization Fate Therapeutics, Inc.|FATE - Total Enterprise Value
- book capitalization data:
Book Value per Share Fate Therapeutics|FATE - Company Net Assets|Market Capitalization to Book Value Ratio fatetherapeutics.com|FATE - Company Total Assets
- debt and liquidity data:
Debt to Equity Fate Therapeutics, Inc.|FATE - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Fate Therapeutics|FATE - Company Total Debt|Debts to Book Capitalization Fate Therapeutics, Inc.
Analysis of all company metrics:Fate Therapeutics Corp, FATE
Manufactured product of fatetherapeutics.com

Book value per share determines the equity portion per security by subtracting all liabilities from total assets to assess the intrinsic value of the business. By analyzing the current book value per share, an investor can see the financial foundation of Fate Therapeutics, Inc. (FATE), which is supported by cost optimization through the outsourcing of clinical trials to external contractors without sacrificing operational control.

Competitor analysis for Fate Therapeutics, Inc.

Accounting Value per Share BeiGene Corp ONC|HALO - Book Price of a Share|Book Value per Share RVMD|ascentage.com (AAPG) - Net Asset Value per Share|Book Value per Share CGON|Accounting Value per Share UroGen Pharma Ltd|Book Value per Share BCAX|Book Value per Share PSNL (Personalis Genomics)|ERAS - Net Assets per Single Share|Equity per Share delcath.com DCTH|YMAB: Book Value per Share|AURA - Accounting Value per Share|Book Value per Share CADL|ARAY (Accuray, Inc.) - Net Asset Value per Share|SLS - Net Assets per Single Share|Accounting Value of a Share actuatetherapeutics.com (ACTU)|Citius Oncology (CTOR) - Accounting Value per Share|Accounting Value of a Share tuhurabio.com (HURA)|Protara - Book Value per Share|WHWK - Accounting Value per Share|TScan - Accounting Value per Share|CSBR: Book Value per Share|Net Assets per Single Share xbiotech.com XBIT|CEL-SCI (CVM) - Accounting Value of a Share|Book Value per Share OSTX (OS Therapies Inc)|Net Asset Value per Share radiopharmtheranostics.com|ARTV - Book Value per Share|Share Book Value adlainortye.com (ANL)|Book Value per Share VERU (Veru)|TPST - Book Value per Share|Accounting Value per Share Xilio XLO|RENB - Book Price of a Share|Book Value per Share MURA|Net Asset Value per Share Kairos Pharma|OKUR - Accounting Value per Share|Accounting Value of a Share CytoMed (GDTC)|Accounting Value per Share Curis, Inc.|Book Price of a Share apollomicsinc.com (APLM)|Book Value per Share Tharimmune, Inc.|Accounting Value of a Share Advanced Biomed Inc. ADVB|GNPX (Genprex) - Book Value per Share|CLDI: Net Asset Value per Share|Net Assets per Single Share Sunshine Biopharma, Inc. SBFM|Xenetic Biosciences, Inc. (XBIO) - Accounting Value of a Share|SLRX (Salarius Pharmaceuticals) - Book Value per Share|Book Value per Share PPBT|AONC - Net Assets per Single Share|Share Book Value BeiGene Ltd. (BGNE)|CKPT: Book Value per Share|ELEV - Net Asset Value per Share|iCAD Corp - Accounting Value per Share|Ikena Oncology, Inc. (IKNA) - Book Value per Share|NTBL - Accounting Value per Share|Viracta Therapeutics, Inc. (VIRX) - Book Price of a Share|MOR: Book Value per Share|Net Assets per Share NAYA Biosciences Corp|Book Value per Share AAPGV (Ascentage Pharma Group)